These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23172729)

  • 1. Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry).
    Kiesz RS; Wiernek SL; Wiernek BK; Radvany MG; Buszman PP; Szymanski R; Konkolewska MD; Martin JL; Buszman PE
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E244-50. PubMed ID: 23172729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study.
    McKinsey JF; Zeller T; Rocha-Singh KJ; Jaff MR; Garcia LA;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):923-33. PubMed ID: 25147039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editor's Choice - Dual Antiplatelet Therapy Improves Outcome in Diabetic Patients Undergoing Endovascular Femoropopliteal Stenting for Critical Limb Ischaemia.
    Thott O; Granath F; Malmstedt J; Wahlgren CM
    Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):403-410. PubMed ID: 28131536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease.
    Armstrong EJ; Anderson DR; Yeo KK; Singh GD; Bang H; Amsterdam EA; Freischlag JA; Laird JR
    J Vasc Surg; 2015 Jul; 62(1):157-165.e1. PubMed ID: 25864042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions.
    Bertges DJ; White R; Cheng YC; Sun T; Ramkumar N; Goodney PP; Wilgus RW; Lottes AE; Smale JA; Drozda J; Raska M; Heise T; Jones WS; Tcheng JE; Eldrup-Jorgensen J; Sedrakyan A; Malone ML; Marinac-Dabic D; Thatcher R; Morales P; Krucoff MW; Cronenwett JL;
    J Vasc Surg; 2021 May; 73(5):1702-1714.e11. PubMed ID: 33080324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center.
    Shammas NW; Shammas GA; Helou TJ; Voelliger CM; Mrad L; Jerin M
    Cardiovasc Revasc Med; 2012; 13(4):224-7. PubMed ID: 22575073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results.
    Cioppa A; Stabile E; Popusoi G; Salemme L; Cota L; Pucciarelli A; Ambrosini V; Sorropago G; Tesorio T; Agresta A; Biamino G; Rubino P
    Cardiovasc Revasc Med; 2012; 13(4):219-23. PubMed ID: 22632996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular treatment of lesions in the below-knee popliteal artery.
    Siracuse JJ; Gill HL; Cassidy SP; Messina MD; Catz D; Egorova N; Parrack I; McKinsey JF
    J Vasc Surg; 2014 Aug; 60(2):356-61. PubMed ID: 24650745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
    Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
    J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries).
    Zeller T; Beschorner U; Pilger E; Bosiers M; Deloose K; Peeters P; Scheinert D; Schulte KL; Rastan A; Brodmann M
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1614-22. PubMed ID: 26493253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry.
    Stavroulakis K; Borowski M; Torsello G; Bisdas T;
    J Vasc Surg; 2017 Nov; 66(5):1534-1542. PubMed ID: 28807382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction.
    Klingelhoefer E; Bergert H; Kersting S; Ludwig S; Weiss N; Schönleben F; Grützmann R; Gäbel G
    J Vasc Surg; 2016 Aug; 64(2):380-388.e1. PubMed ID: 27763266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distal embolization during lower extremity endovascular interventions.
    Ochoa Chaar CI; Shebl F; Sumpio B; Dardik A; Indes J; Sarac T
    J Vasc Surg; 2017 Jul; 66(1):143-150. PubMed ID: 28366300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM; Hyder ON; Soukas PA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reinterventions in Patients with Claudication and Chronic Limb Threatening Ischemia.
    Mohamedali A; Kiwan G; Kim T; Zhang Y; Zhuo H; Tonnessen B; Dardik A; Chaar CIO
    Ann Vasc Surg; 2022 Feb; 79():56-64. PubMed ID: 34656724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions.
    Alameddine D; Damara FA; Pinto Rodriguez P; Huttler J; Slade MD; Arhuidese I; Aboian E; Ochoa Chaar CI
    Ann Vasc Surg; 2024 Jun; 103():47-57. PubMed ID: 38387798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of intermediate term clinical outcome after endovascular below-knee interventions.
    Köhler C; Halbritter K; Stroszczynski C; Mahlmann A; Beyer-Westendorf J; Weiss N
    Vasa; 2012 Nov; 41(6):440-50. PubMed ID: 23129040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal medical management before lower extremity bypass for claudication in the veteran population.
    Williams CR; Jellison A; Martin L; Zhang C; Presson AP; Kraiss LW; Brooke BS
    J Vasc Surg; 2019 Feb; 69(2):545-554. PubMed ID: 30108008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.